Storage lesions of blood products intended for transfusion have been shown to give rise to the accumulation of proin flammatory cytokines, which are known to cause transfusion associated adverse events and immunomodulatory effects. Regulations which determine the eligibility of b...
Open access
Research Article10.9734/jammr/2021/v33i2431239
Platelet concentrates (PCs) are widely used in transfusion medicine for therapeutic purposes and their demand is constantly on the rise. Current storage regulations make this product highly susceptible to bacterial contaminations and platelet storage lesions (PSL) causing the nee...
Open access
Research Article10.9734/ibrr/2023/v14i4318
Platelets are small, anuclear blood cells derived from megakaryocytes in the bone marrow. Their role is to stop bleeding (haemostasis) during haemorrhage and are also used as part of cancer treatment. Hence, the importance and demand for platelet concentrates (PCs) should never b...
Platelets are small anucleate cell fragments found in the blood, which originate from large cells known as megakaryocytes. Platelets are widely used in transfusion medicine for therapeutic purposes. Platelet transfusions are beneficial for patients who are experiencing thrombocyt...
Aims: The necessity for Platelet Concentrates (PCs) in transfusion has increased, and several measures have been undertaken to try and increase the shelf-life of this product. Increasing the shelf-life to 10 days from the current 5 days will increase availability and reduce waste...
Open access
Research Article10.9734/jammr/2022/v34i2131553